Today: 8 June 2026
Ramelius Resources (ASX:RMS) share price slides 6.6% as bullion rout hits gold miners
2 February 2026
2 mins read

Ramelius Resources (ASX:RMS) share price slides 6.6% as bullion rout hits gold miners

Sydney, Feb 2, 2026, 17:38 AEDT — The market has closed.

  • Ramelius fell 6.6% on Monday, dragged down by a broad selloff hitting gold miners amid slipping precious metals prices.
  • The broader Australian market slipped roughly 1%, dragged down mainly by materials.
  • Traders are eyeing Tuesday’s RBA decision and watching to see if the forced selling in metals slows down.

Ramelius Resources shares dropped 6.57%, closing at A$4.41 on Monday, dragged down by broad selling in precious metals hitting Australian gold miners hard.

Gold and silver prices dropped further after CME Group hiked margin requirements—the cash traders must put up to maintain futures positions—following last week’s steep selloff sparked by reports that Donald Trump might nominate Kevin Warsh to head the U.S. central bank. Tim Waterer, chief market analyst at KCM Trade, attributed the move to “forced liquidations and margin increases.” Reuters

This is significant for Ramelius today since its stock now acts as a direct gauge of bullion sentiment. Strong realised prices boosted cash flow last quarter, but the market can shift fast once leverage disappears from commodities.

The S&P/ASX 200 slipped nearly 1% on Monday, dragged down by materials. Trading Economics highlighted steep losses among major gold miners—Newmont Corporation, Evolution Mining, and Northern Star Resources all fell between about 5.6% and 10%. Eyes now turn to Tuesday’s Reserve Bank of Australia decision, where a 25 basis point rate hike is widely anticipated.

Ramelius revealed in a Monday investor presentation that it produced 45,610 ounces of gold in the December quarter, with an all-in sustaining cost (AISC) of A$1,977 per ounce—a figure covering ongoing operating expenses and sustaining capital. Operating cash flow came in at A$149.7 million. The presentation also showed closing cash and gold holdings of A$694.3 million as of Dec. 31. The company flagged a A$250 million share buyback and raised its minimum dividends for FY26 and FY27. It noted first ore was mined from the Never Never underground mine during the quarter, with haulage set to begin in late February or March. Ore from Dalgaranga is expected to be available starting March.

The bigger market story remains deleveraging. Christopher Forbes, head of Asia and Middle East at CMC Markets, described it as “risk off and de-leveraging — a flushing out of leverage in the system” in a Reuters “Instant View” on the wider selloff. Reuters

But things could still get more complicated. Continued margin calls pushing sales might keep gold equities under pressure, even if spot prices level off. On top of that, cost assumptions in mine plans could quickly become outdated.

The currency will be in focus this week. Any unexpected move from the RBA could shake the Australian dollar, which miners watch closely since gold trades in U.S. dollars worldwide. A stronger Aussie can squeeze earnings when converted back into Australian dollars, if only slightly.

Tuesday’s RBA decision takes center stage, with markets focused on its implications for rates, the dollar, and risk appetite. Investors in Ramelius will be keeping a close eye on buyb

ack momentum and any additional details on commissioning and ore movement as the late-February and March deadlines near.

Stock Market Today

  • KOSPI Index Plunges Amid Global Market Turmoil
    June 8, 2026, 9:07 AM EDT. South Korea's KOSPI experienced a sharp crash triggered by margin stress in chip stocks and a circuit breaker trading halt. The selloff in global markets was fueled by a strong U.S. jobs report signaling prolonged high interest rates, fears of a yen carry trade unwind amid Bank of Japan tightening, and a crypto selloff following Zcash network vulnerabilities. U.S. futures rebounded slightly as chip stocks recovered, with investors focused on upcoming inflation data and SpaceX's anticipated IPO. Rising Middle East tensions keep oil prices elevated near $94 per barrel. The volatile market reflects growing concerns over liquidity absorption from the SpaceX listing, geopolitical risks, and tightening monetary policies globally.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Telstra share price bucks ASX slide as miners sink; RBA call and Feb results loom
Previous Story

Telstra share price bucks ASX slide as miners sink; RBA call and Feb results loom

ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency
Next Story

ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency

Go toTop